Visual dysfunction associated with diabetic retinopathy

Current Diabetes Reports

Volumn 10, Issue 5, 2010, Pages 380-384

  Jackson, Gregory R ^a   Barber, Alistair J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Diabetic retinopathy; Electrophysiology; Human; Psychophysics

Indexed keywords

DARK ADAPTATION; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; ELECTRORETINOGRAM; HUMAN; LASER COAGULATION; OPTICAL COHERENCE TOMOGRAPHY; PHOTOTRANSDUCTION; RETINA BLOOD VESSEL; RETINA DEGENERATION; RETINA GANGLION CELL; RETINA ROD; REVIEW; VISUAL IMPAIRMENT;

DIABETIC RETINOPATHY; HUMANS; RETINA; VISION DISORDERS;

EID: 77956267091     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-010-0132-4     Document Type: Review

References (44)

1. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group [no authors listed]. Ophthalmology 1991, 98(5 Suppl):766-785.
2. Diabetic Retinopathy Clinical Research Network: A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008, 115:1447-1449, 1449.e1441-1449.e1410.
3. RW Beck AR Edwards LP Aiello, et al. 2009 Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema Arch Ophthalmol 127 245 251 10.1001/archophthalmol.2009.109 19273785
4. LP Aiello AR Edwards RW Beck, et al. 2010 Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema Ophthalmology 117 946 953 10.1016/j.ophtha.2009.10.002 20122739
5. IU Scott AR Edwards RW Beck, et al. 2007 A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema Ophthalmology 114 1860 1867 10.1016/j.ophtha.2006.08.054 17698196
6. Diabetic Retinopathy Clinical Research Network MJ Elman LP Aiello, et al. 2010 Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema Ophthalmology 117 1064 1077.e35 10.1016/j.ophtha.2010.02.031 20427088 This article demonstrates ranibizumab in combination improves vision in patients with DME. It provides hope for treatments of DME that may preserve vision better than laser, which ablates the retina
7. QD Nguyen SM Shah JS Heier, et al. 2009 Primary end point (six months) results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study Ophthalmology 116 2175 2181.e1 10.1016/j.ophtha.2009.04.023 19700194
8. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group [no authors listed]. Ophthalmology 1981, 88:583-600.
9. GH Bresnick 1986 Diabetic retinopathy viewed as a neurosensory disorder Arch Ophthalmol 104 989 990 1:STN:280:DyaL283mvVGjtQ%3D%3D 3729794
10. •• Gardner T, Abcouwer S, Antonetti D, et al.: Pathogenesis of diabetic retinopathy. Arch Ophthalmol 2010, in press. Gardner et al. present the case that DR should be viewed as a neurodegenerative disease much as other complications of diabetes such as neuropathy are viewed. A comprehensive approach to the study of DR is proposed that integrates the best of basic and translational research.
11. JR Wolter 1961 Diabetic retinopathy Am J Ophthalmol 51 1123 1141 1:STN:280:DyaF3c7gs1Ogtw%3D%3D 13786453
12. AJ Barber DA Antonetti TS Kern, et al. 2005 The Ins2Akita mouse as a model of early retinal complications in diabetes Invest Ophthalmol Vis Sci 46 2210 2218 10.1167/iovs.04-1340 15914643
13. AJ Barber E Lieth SA Khin, et al. 1998 Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin J Clin Invest 102 783 791 10.1172/JCI2425 1:CAS:528:DyaK1cXlsFaqsrg%3D 9710447
14. MJ Gastinger AR Kunselman EE Conboy, et al. 2008 Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice Invest Ophthalmol Vis Sci 49 2635 2642 10.1167/iovs.07-0683 18515593
15. M Parravano F Oddone D Mineo, et al. 2008 The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes Br J Ophthalmol 92 1656 1660 10.1136/bjo.2008.143057 1:STN:280:DC%2BD1cjls1Gltg%3D%3D 18829632
16. R Parikh M Naik A Mathai, et al. 2006 Role of frequency doubling technology perimetry in screening of diabetic retinopathy Indian J Ophthalmol 54 17 22 10.4103/0301-4738.21609 16531665
17. PA Sieving C Nino 1988 Scotopic threshold response (STR) of the human electroretinogram Invest Ophthalmol Vis Sci 29 1608 1614 1:STN:280: DyaL1M%2Fjt12ktQ%3D%3D 3182195
18. GW Aylward FA Billson 1989 The scotopic threshold response in diabetic retinopathy-a preliminary report Aust N Z J Ophthalmol 17 369 372 10.1111/j.1442-9071.1989.tb00556.x 1:STN:280:DyaK3c7ms1CntQ%3D%3D 2624727
19. S Caputo MA Di Leo B Falsini, et al. 1990 Evidence for early impairment of macular function with pattern ERG in type I diabetic patients Diabetes Care 13 412 418 10.2337/diacare.13.4.412 1:STN:280:DyaK3c3gtVOisQ%3D%3D 2318101
20. GH Bresnick M Palta 1987 Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy Arch Ophthalmol 105 929 933 1:STN:280:DyaL2s3ntValtQ%3D%3D 3606452
21. M Vadala M Anastasi G Lodato S Cillino 2002 Electroretinographic oscillatory potentials in insulin-dependent diabetes patients: a long-term follow-up Acta Ophthalmol Scand 80 305 309 10.1034/j.1600-0420.2002.800314.x 12059871
22. GH Bresnick M Palta 1987 Predicting progression to severe proliferative diabetic retinopathy Arch Ophthalmol 105 810 814 1:STN:280:DyaL2s3ht1Onuw%3D%3D 3579713
23. HW van Dijk PH Kok M Garvin, et al. 2009 Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy Invest Ophthalmol Vis Sci 50 3404 3409 10.1167/iovs.08-3143 19151397
24. HW Van Dijk FD Verbraak PH Kok, et al. 2010 Decreased retinal ganglion cell layer thickness in type 1 diabetic patients Invest Ophthalmol Vis Sci 51 3660 3665 10.1167/iovs.09-5041 20130282
25. D Cabrera DeBuc GM Somfai 2010 Early detection of retinal thickness changes in diabetes using optical coherence tomography Med Sci Monit 16 MT15 MT21 20190693
26. H Takahashi T Goto T Shoji, et al. 2006 Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry Am J Ophthalmol 142 88 94 10.1016/j.ajo.2006.02.016 16815255
27. DB Henson DE Williams 1979 Normative and clinical data with a new type of dark adaptometer Am J Optom Physiol Opt 56 267 271 1:STN:280: DyaL3c%2FosFGksQ%3D%3D 517628
28. VC Greenstein SR Thomas H Blaustein, et al. 1993 Effects of early diabetic retinopathy on rod system sensitivity Optom Vis Sci 70 18 23 10.1097/00006324-199301000-00005 1:STN:280:DyaK3s7lslSmtg%3D%3D 8430004
29. K Holopigian W Seiple M Lorenzo R Carr 1992 A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy Invest Ophthalmol Vis Sci 33 2773 2780 1:STN:280:DyaK38vgs1ersA%3D%3D 1526726
30. FA Abraham J Haimovitz M Berezin 1988 The photopic and scotopic visual thresholds in diabetics without diabetic retinopathy Metab Pediatr Syst Ophthalmol 11 76 77 1:STN:280:DyaL1MzmsVagtw%3D%3D 3255873
31. K Holopigian VC Greenstein W Seiple, et al. 1997 Evidence for photoreceptor changes in patients with diabetic retinopathy Invest Ophthalmol Vis Sci 38 2355 2365 1:STN:280:DyaK1c%2FgtlSntg%3D%3D 9344359
32. M Mantyjarvi 1989 Colour vision and dark adaptation in diabetic patients after photocoagulation Acta Ophthalmol (Copenh) 67 113 118 10.1111/j.1755-3768. 1989.tb00738.x 1:STN:280:DyaL1M3mvFGmtQ%3D%3D
33. DB Henson RV North 1979 Dark adaptation in diabetes mellitus Br J Ophthalmol 63 539 541 10.1136/bjo.63.8.539 1:STN:280:DyaL3c%2FgtVeltQ%3D%3D 476028
34. PM Pender WE Benson H Compton GB Cox 1981 The effects of panretinal photocoagulation on dark adaptation in diabetics with proliferative retinopathy Ophthalmology 88 635 638 1:STN:280:DyaL3M3ntFKksw%3D%3D 7196565
35. GB Arden JE Wolf Y Tsang 1998 Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis Vision Res 38 1723 1729 10.1016/S0042-6989(98)00004-2 1:STN:280:DyaK1cvhvFKnsA%3D%3D 9747505
36. A Harris O Arend RP Danis, et al. 1996 Hyperoxia improves contrast sensitivity in early diabetic retinopathy Br J Ophthalmol 80 209 213 10.1136/bjo.80.3.209 1:STN:280:DyaK283ks1OjtA%3D%3D 8703857
37. SK Holfort K Klemp PK Kofoed, et al. 2010 Scotopic electrophysiology of the retina during transient hyperglycemia in type 2 diabetes Invest Ophthalmol Vis Sci 51 2790 2794 10.1167/iovs.09-4891 20042648
38. A Verrotti L Lobefalo E Altobelli, et al. 2001 Static perimetry and diabetic retinopathy: a long-term follow-up Acta Diabetol 38 99 105 10.1007/s005920170021 1:STN:280:DC%2BD38%2FjtFGiug%3D%3D 11757809
39. B Bengtsson A Heijl E Agardh 2005 Visual fields correlate better than visual acuity to severity of diabetic retinopathy Diabetologia 48 2494 2500 10.1007/s00125-005-0001-x 1:STN:280:DC%2BD2Mnjsl2ksg%3D%3D 16261313
40. VC Greenstein DC Hood R Ritch, et al. 1989 S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma Invest Ophthalmol Vis Sci 30 1732 1737 1:STN:280:DyaL1MzjvF2juw%3D%3D 2759788
41. NC Cho GL Poulsen JN Ver Hoeve TM Nork 2000 Selective loss of S-cones in diabetic retinopathy Arch Ophthalmol 118 1393 1400 1:STN:280: DC%2BD3cvpvFaksQ%3D%3D 11030822
42. E Agardh H Stjernquist A Heijl B Bengtsson 2006 Visual acuity and perimetry as measures of visual function in diabetic macular oedema Diabetologia 49 200 206 10.1007/s00125-005-0072-8 1:STN:280:DC%2BD28%2FltVGisQ%3D%3D 16341838
43. K Frost-Larsen HW Larsen 1985 Macular recovery time recorded by nyctometry-a screening method for selection of patients who are at risk of developing proliferative diabetic retinopathy. Results of a 5-year follow-up Acta Ophthalmol Suppl 173 39 47 10.1111/j.1755-3768.1985.tb06836.x 1:STN:280:DyaL28%2FpvFKgtg%3D%3D 3002099
44. K Frost-Larsen C Lund-Anderson K Starup 1989 Macular recovery during onset and development of diabetic retinopathy in childhood and adolescence Acta Ophthalmol (Copenh) 67 401 404 10.1111/j.1755-3768.1989.tb01623.x 1:STN:280:DyaK3c%2Fit1CgsQ%3D%3D